Spotlight
Specialty
Partners
CME/CE
A New Wave of Progress in the Treatment of Renal Cell Carcinoma: Highlights from ASCO GU 2023 and Beyond : Episode 1
Risk Stratification of Patients with Metastatic Renal Cell Carcinoma (RCC)
Moshe Ornstein, MD, MA, starts a conversation on how patients with metastatic renal cell carcinoma are classified by risk, and how risk category influences approaches to systemic therapy.
Now Viewing
EP: 1.Risk Stratification of Patients with Metastatic Renal Cell Carcinoma (RCC)
EP: 2.Patient Profile Presentation: A 65-Year-Old Woman With Metastatic RCC
EP: 3.Cabozantinib plus Nivolumab for the Frontline Treatment of Metastatic RCC: Updates From CheckMate 9ER
EP: 4.Considerations When Deciding Between an IO/TKI and IO/IO Treatment Regimen for a Patient With RCC
Related Videos
Related Content
